Alexion Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2021 to a ratio of 4.4, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Alexion Pharmaceuticals Inc in Mar 31 2021 quarter, has decreased to 83 days, compared to 84 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector 467 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2021 from 2966 to 3098.

What is Receivable Turnover Ratio?
What is Alexion Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALXN Receivables Turnover Ratio	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter
Y / Y Receivable Change	9.5 %	13.36 %	28.74 %	22.13 %	32.36 %
Y / Y Revenue Change	13.27 %	14.99 %	25.78 %	20.05 %	26.69 %
Receivable Turnover Ratio (TTM)	4.4	4.36	4.34	4.36	4.39
ALXN's Total Ranking	# 3098	# 2966	# 2862	# 2315	# 2860
Accounts Receivable average collection period days	83	84	84	84	83
Seq. Receivable Change	4.52 %	-1.93 %	4.73 %	2.01 %	8.2 %
Seq. Revenue Change	2.81 %	0.2 %	9.98 %	-0.01 %	4.37 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 155
Healthcare Sector	# 468
Overall Market	# 3098

Receivable Turnover Ratio Statistics
High	Average	Low
15.35	5.17	4.12
(Dec. 31, 2012)		(Dec 31 2013)

ALXN Company Profile • Back to ALXN Efficiency Comparisons • Compare ALXN Receivables Turnover Ratio to its Competitors

Financial Statements
Alexion Pharmaceuticals Inc 's Accounts Receivable	$ 1,473 Millions	Visit ALXN's Balance sheet
Alexion Pharmaceuticals Inc 's Sales TTM	$ 6,262 Millions	Visit ALXN's Income Statement
Sources of ALXN's Revenues		Visit ALXN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALXN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALXN's Growth Rates	ALXN's Roa	ALXN's Inventory Turnover Ratio	ALXN's Dividend Comparisons
ALXN's Profitability Ratios	ALXN's Roi	ALXN's Asset Turnover Ratio	ALXN's Dividend Growth
ALXN's Valuation Ratios	ALXN's Roe	ALXN's Financial Strength Ratios	ALXN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2021	Receivable at quarter ending Mar 31 2021
National Healthcare Corp	11.55	$ 1,023.066 Millions	$ 88.602 Millions
Chembio Diagnostics Inc	11.52	$ 34.335 Millions	$ 2.981 Millions
Xenon Pharmaceuticals Inc	11.46	$ 29.446 Millions	$ 2.569 Millions
Allied Healthcare Products inc	11.42	$ 37.771 Millions	$ 3.308 Millions
Strongbridge Biopharma plc	11.36	$ 32.439 Millions	$ 2.857 Millions
Viemed Healthcare Inc	11.29	$ 135.919 Millions	$ 12.043 Millions
Integrated Biopharma Inc	11.25	$ 60.036 Millions	$ 5.339 Millions
Morphic Holding inc	11.19	$ 42.616 Millions	$ 3.810 Millions
Novavax inc	11.10	$ 919.450 Millions	$ 82.816 Millions
Vaso Corporation	11.08	$ 69.086 Millions	$ 6.235 Millions
American Bio Medica Corporation	10.93	$ 3.984 Millions	$ 0.365 Millions
Lifeloc Technologies Inc	10.81	$ 6.148 Millions	$ 0.569 Millions
Insulet Corporation	10.75	$ 958.700 Millions	$ 89.150 Millions
Teladoc Health Inc	10.71	$ 1,366.838 Millions	$ 127.582 Millions
Scienture Holdings Inc	10.65	$ 17.972 Millions	$ 1.687 Millions
Puma Biotechnology Inc	10.58	$ 272.062 Millions	$ 25.706 Millions
Dmk Pharmaceuticals Corporation	10.57	$ 9.825 Millions	$ 0.929 Millions
Sunlink Health Systems Inc	10.51	$ 44.473 Millions	$ 4.231 Millions
Pressure Biosciences Inc	10.47	$ 1.527 Millions	$ 0.146 Millions
Ontrak Inc	10.41	$ 99.221 Millions	$ 9.533 Millions
Musclepharm Corporation	10.40	$ 61.330 Millions	$ 5.898 Millions
Insmed Inc	10.39	$ 167.767 Millions	$ 16.140 Millions
Utah Medical Products Inc	10.35	$ 42.240 Millions	$ 4.083 Millions
Procyon Corporation	10.24	$ 4.338 Millions	$ 0.423 Millions
Veru Inc	10.13	$ 50.028 Millions	$ 4.937 Millions
Kushco Holdings Inc	10.10	$ 108.585 Millions	$ 10.749 Millions
Crispr Therapeutics Ag	10.08	$ 1.101 Millions	$ 0.109 Millions
Enzo Biochem Inc	10.05	$ 112.445 Millions	$ 11.191 Millions
Dicerna Pharmaceuticals Inc	10.02	$ 177.882 Millions	$ 17.755 Millions
Capforce Inc	9.87	$ 4.427 Millions	$ 0.448 Millions

Date modified: 2026-09-12T06:12:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.